Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1012431

registered interest
date	22/11/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Home Office: Written Questions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, for what reason his Department has not answered Question 181236 on Armed Conflict: Capital Punishment, asked on 18 October 2018.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	194671
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>The reponse for UIN 181326 was given on the 14th February 2019.</p> answering member constituency Wyre and Preston North answering member printed Mr Ben Wallace question first answered 14/02/2019 16:59:51 answering member 1539 label Biography information for Mr Ben Wallace
tabling member	3930 label Biography information for Caroline Lucas

1023994

registered interest
date	12/12/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Home Office: Written Questions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, whether he has plans to publish the answer to Question 181236 tabled on 18 October 2018 and Question 194671 tabled on 22 November 2018 on Armed Conflict: Capital Punishment before the Christmas recess.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	201611
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>The responses for UIN 181236 and 194671 were given on the 14th February 2019.</p> answering member constituency Wyre and Preston North answering member printed Mr Ben Wallace question first answered 14/02/2019 17:04:48 answering member 1539 label Biography information for Mr Ben Wallace
tabling member	3930 label Biography information for Caroline Lucas

1055821

registered interest
date	06/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Strokes: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding his Department has allocated to the development of a national stroke plan.
tabling member constituency	Birmingham, Northfield
tabling member printed	Richard Burden
uin	217450
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>Improving care for people who suffer stroke, and preventing strokes, are priorities for the National Health Service as set out in the recently published NHS Long Term Plan. Building on the learning and success of the previous National Stroke strategy, NHS England will work with partners across the system to lead a programme which will drive the next step change in the care stroke patients receive. As well as significant investment in early cardiovascular disease detection and prevention, this will include funding major increases in the number of patients benefitting from potentially life-changing treatment to dissolve or remove blood clots. Further investment in higher intensity models for stroke rehabilitation will ensure patients have the best chance of returning to employment or independence, experiencing reduced disability and improved support for cognitive and psychological need.</p><p> </p><p>Further information on funding will be set out in the implementation framework for the Long Term Plan, due to be published in the spring.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/02/2019 17:30:56 answering member 4067 label Biography information for Steve Brine
tabling member	301 label Biography information for Richard Burden

1055851

registered interest
date	06/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	General Practitioners: Recruitment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the forthcoming workforce implementation plan will include a plan to increase the number of general practitioners.
tabling member constituency	Wantage
tabling member printed	Mr Edward Vaizey
uin	217514
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>The NHS Long Term Plan, published 7 January 2019, sets out a vital strategic framework to ensure that over the next 10 years the National Health Service will have the staff it needs. This included the commitment to deliver a net increase of 5,000 general practitioners (GPs) as soon as possible.</p><p>The publication of ‘Investment and evolution: A five-year framework for GP contract reform to implement the NHS Long Term Plan’ in January 2019 confirmed that NHS England will now extend a number of general practice programmes for a five year period until 2023/24 to help deliver against this commitment.</p><p>Further plans to support delivery will be set out in the NHS workforce implementation plan due to be published later this year. This plan will build on the General Practice Forward View to increase the number of doctors working in general practice and will also continue recent provision for a range of other roles.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/02/2019 17:28:12 answering member 4067 label Biography information for Steve Brine
tabling member	1580 label Biography information for Lord Vaizey of Didcot

1055916

registered interest
date	06/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people have accessed cannabis-derived medicinal products under schedule 2 of the Misuse of Drugs Regulations 2001.
tabling member constituency	Leigh
tabling member printed	Jo Platt
uin	217660
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>NHS England has set up systems to monitor the prescribing of cannabis-based products for medicinal use via the NHS Business Services Authority and NHS England Controlled Drugs Accountable Officers. We expect the first data to be available by the end of March 2019.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/02/2019 17:29:40 answering member 4067 label Biography information for Steve Brine
tabling member	4673 label Biography information for Jo Platt

1055922

registered interest
date	06/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to his Answer of 5 February 2019 to Question 213249 on Diabetes: Medical Equipment, what role integrated care systems will play in ensuring that people with diabetes are able to access their preferred glucose meter.
tabling member constituency	Knowsley
tabling member printed	Mr George Howarth
uin	217483
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>Integrated care systems (ICSs) are partnerships made of National Health Service organisations, local councils and others to take collective responsibility for managing resources, delivering NHS standards, and improving the health of the population they serve. Clinical commissioning groups (CCGs) are central partners in ICSs. CCGs will continue to be responsible for making commissioning decisions in an ICS. We expect that, working with their partners in an ICS, CCGs will continue to support people with diabetes to access their preferred glucose monitoring device in line with best practice clinical guidance.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/02/2019 17:24:12 answering member 4067 label Biography information for Steve Brine
tabling member	481 label Biography information for Sir George Howarth

1055929

registered interest
date	06/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer on 5 February 2019 to Question 213317 on NHS: Drugs, what process NICE plans to follow when scoping its review of its technology appraisal methods in the 2019-20 business year.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	217532
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is in the process of planning how to conduct its scoping of the review of the methods for technology appraisal. Scoping will involve industry and other relevant stakeholders, including patient organisations, however, these details are still being planned. More information will be made available on the NICE website in due course.<strong></strong></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 217533 question first answered 14/02/2019 17:29:00 answering member 4067 label Biography information for Steve Brine
tabling member	3930 label Biography information for Caroline Lucas

1055930

registered interest
date	06/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer on 5 February 2019 to Question 213317 on NHS: Drugs, how NICE plans to engage with patient organisations as part of its scoping process for its review of its technology appraisal methods in the 2019-20 business year.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	217533
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is in the process of planning how to conduct its scoping of the review of the methods for technology appraisal. Scoping will involve industry and other relevant stakeholders, including patient organisations, however, these details are still being planned. More information will be made available on the NICE website in due course.<strong></strong></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 217532 question first answered 14/02/2019 17:29:00 answering member 4067 label Biography information for Steve Brine
tabling member	3930 label Biography information for Caroline Lucas

1055952

registered interest
date	06/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Biosimilar Medicines
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that hospital trusts adhere to (a) shared decision-making principles and (b) patient consent guidance within NHS England's Commissioning framework for biological medicines (including biosimilar medicines) when implementing bio-similar medicine switching programmes.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	217619
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>NHS England has issued guidance around the commissioning of biological medicines and expects clinical commissioning groups (CCGs) to give due consideration to this guidance. The framework sets out the importance of developing local policies to support switching patients to biosimilars in line with best practice and where appropriate. The commissioning framework set out policy based on best practice but ultimately CCGs and hospital trusts are accountable for their own local decision making.</p><p><strong> </strong></p><p>All National Health Service organisations have a responsibility to encourage a shift in moving to shared decision making, and in ensuring that all patient consultations are done with a focus on shared decision making, and are happening at an individual healthcare professional/patient level.</p><p> </p><p>NHS England has also made clear that the decision to prescribe a biological medicine for an individual patient, whether an originator or biosimilar, or to change between the two, rests with the responsible prescriber in consultation with the patient, in line with the principles of shared decision making.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 217620 217621 217623 question first answered 14/02/2019 17:32:00 answering member 4067 label Biography information for Steve Brine
tabling member	4398 label Biography information for Chris Green

1055953

registered interest
date	06/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Biosimilar Medicines
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps are taken in cases where guidance within NHS England's Commissioning framework for biological medicines for biological medicines (including biosimilar medicines) is shown not to have been taken and patients are switched to a different medicine without their knowledge or consent.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	217620
answer	answer is ministerial correction date of answer 14/02/2019 answer text <p>NHS England has issued guidance around the commissioning of biological medicines and expects clinical commissioning groups (CCGs) to give due consideration to this guidance. The framework sets out the importance of developing local policies to support switching patients to biosimilars in line with best practice and where appropriate. The commissioning framework set out policy based on best practice but ultimately CCGs and hospital trusts are accountable for their own local decision making.</p><p><strong> </strong></p><p>All National Health Service organisations have a responsibility to encourage a shift in moving to shared decision making, and in ensuring that all patient consultations are done with a focus on shared decision making, and are happening at an individual healthcare professional/patient level.</p><p> </p><p>NHS England has also made clear that the decision to prescribe a biological medicine for an individual patient, whether an originator or biosimilar, or to change between the two, rests with the responsible prescriber in consultation with the patient, in line with the principles of shared decision making.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 217619 217621 217623 question first answered 14/02/2019 17:32:00 answering member 4067 label Biography information for Steve Brine
tabling member	4398 label Biography information for Chris Green